Page last updated: 2024-11-11

amesergide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

amesergide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9821951
CHEMBL ID160293
SCHEMBL ID121670
MeSH IDM0183109

Synonyms (25)

Synonym
gtpl199
(6ar,9r,10ar)-n-cyclohexyl-7-methyl-4-propan-2-yl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
amesergide (usan/inn)
D02893
121588-75-8
ly237733
amesergide [usan:inn]
ergoline-8-carboxamide, n-cyclohexyl-6-methyl-1-(1-methylethyl)-, (8-beta)-
n-cyclohexyl-1-isopropyl-6-methylergoline-8beta-carboxamide
ergoline-8-carboxamide, n-cyclohexyl-6-methyl-1-(1-methylethyl)-, (8beta)-
amesergide
ly-237733
CHEMBL160293
ejl329h95r ,
unii-ejl329h95r
amesergide [mart.]
amesergide [usan]
amesergide [inn]
amesergide [who-dd]
ergoline-8-carboxamide, n-cyclohexyl-6-methyl-1-(1-methylethyl)-, (8.beta.)-
SCHEMBL121670
DTXSID8052851
(8beta)-n-cyclohexyl-1-isopropyl-6-methylergoline-8-carboxamide
KEMOOQHMCGCZKH-JMUQELJHSA-N
Q27074433

Research Excerpts

Overview

Amesergide is an orally active ergoline amide, 5-HT2-receptor antagonist with a long duration of action.

ExcerptReferenceRelevance
"Amesergide is an orally active ergoline amide, 5-HT2-receptor antagonist with a long duration of action. "( Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.
Calligaro, DO; Cohen, ML; Fuller, RW; Kurz, KD, 1994
)
1.98
"Amesergide is a selective serotonin 5-HTIC/2 receptor antagonist being developed for the treatment of depression. "( Developmental toxicity of amesergide administered by gavage to CD rats and New Zealand white rabbits.
Kelich, SL; Meade, PL; Seyler, DE, 1995
)
2.03

Dosage Studied

ExcerptRelevanceReference
" Pregnant rats and rabbits were dosed once daily by gavage on Gestation Days 6-17 and 6-18, respectively."( Developmental toxicity of amesergide administered by gavage to CD rats and New Zealand white rabbits.
Kelich, SL; Meade, PL; Seyler, DE, 1995
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1346919Rat 5-HT2A receptor (5-Hydroxytryptamine receptors)1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID624228Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT2B1993Molecular pharmacology, Mar, Volume: 43, Issue:3
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
AID624223Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID624222Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT2A1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID1346903Rat 5-HT2B receptor (5-Hydroxytryptamine receptors)1993Molecular pharmacology, Mar, Volume: 43, Issue:3
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
AID1259419Human 5-HT2A receptor (5-Hydroxytryptamine receptors)1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID5040Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein1990Journal of medicinal chemistry, Feb, Volume: 33, Issue:2
(8 beta)-6-methylergoline amide derivatives as serotonin antagonists: N1-substituent effects on vascular 5HT2 receptor activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (92.31)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.02 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (37.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other9 (56.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]